Hematopoietic stem cells can be CD34+ or CD34-.
Until recently, it was thought that the most primitive HSC have a fixed phenotype within a hierarchical differentiation system, and that changes in engraftment and renewal potential occur in a stepwise fashion linked with differentiation. In this review, we summarize the data from several different species and different animal models of hematopoietic stem cell function. Taking into account all of the published data, it becomes clear that the hematopoietic stem cell compartment contains more than one phenotypically identifiable population capable of self-renewal and long term pluripotent engraftment. It is clear that some stem cells express CD34, and others do not. The exact phenotypic progression between these cells needs to be further defined, because different in vivo and ex vivo manipulations may shift the stem cells from one phenotype to another, and this can complicate interpretation of experimental transplant data.
Donnelly
D S
DS
Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Krause
D S
DS
D000818:Animals; D018952:Antigens, CD34 / Q000097:blood / Q000378:metabolism / Q000502:physiology*; D019070:Cell Lineage / Q000235:genetics; D006410:Hematopoiesis; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000276:immunology*; D006801:Humans; D016130:Immunophenotyping; D010641:Phenotype
D018952:Antigens, CD34